All media resources and updates in one place.

We prioritise strong media relations to boost our brand visibility and build trust with our audience. Our team engages with journalists and influencers, sharing our innovative approaches and success stories. Transparent communication is essential for lasting relationships, and we keep the media updated on our latest developments.

Recent Updates and Media Releases

Same purpose, stronger identity: mylife Diabetes Care takes next step as an independent diabetes care company

The new global identity reflects the company’s purpose and focus, while supporting the transition to mylife Diabetes Care AG as legal manufacturer.

Asian businesswoman checking messages on her mobile phone while leaning against a wall, with a diverse group of busy colleagues collaborating in the background of their modern office

mylife Diabetes Care and Glooko Expand Diabetes Data Management Partnership

Latest agreement supports connected diabetes data management for people using mylife Loop powered by CamAPS FX, as well as their healthcare teams

mylife Diabetes Care and CamDiab introduce the latest innovation from CamDiab: CamAPS Liberty – the first fully closed-loop option within myLoop

CamAPS Liberty is a new feature within the CamAPS FX app for people living with type 1 diabetes, designed to help reduce the daily decision burden and provide greater flexibility, particularly at key moments in their lifelong journey.

Health Canada approves expanded compatibility for myLoop with iOS and Abbott’s FreeStyle Libre 3 Plus Sensor

myLoop powered by CamAPS FX becomes the first automated insulin delivery system in Canada compatible with two glucose monitoring systems for people living with type 1 diabetes.

mylife Diabetes Care moves into new headquarters in Burgdorf

Burgdorf, 05 November 2025 – Ypsomed Diabetes Care AG becomes mylife Diabetes Care AG and has moved into its new headquarters at Lyssachstrasse 40 in Burgdorf. With its new name and new headquarters, the company underlines its independence and ambition as a global leader in insulin pump therapy – innovative, reliable, and fully dedicated to the needs of people living with diabetes.

New name, same mission: mylife Diabetes Care AG will continue to innovate for people with diabetes

Ypsomed Diabetes Care AG will become mylife Diabetes Care AG, a company fully dedicated to improving the lives of people living with diabetes. The new name builds on the established mylife Diabetescare portfolio and reflects the company’s long-standing commitment to innovation in insulin infusion systems.

Press Contact

Thomas Kutt

Head of Global Communications

thomas.kutt@mylife-diabetescare.comFor any press inquiries, feel free to contact our dedicated media relations team. We are ready to help you with any questions or requests you might have, ensuring you receive the information you need promptly.